Table 1.

Patient Information for Lymphoepithelial Carcinomas of Salivary Gland

No	Age (years)/sex/race	Site/side/size (cm)	Symptom duration (months)	Unique clinical findings	LESA	pT	pN	AJCC8 Stage Group	EBER	Treatment	Status (years)
1	18 F A	S R 2.6	3		+	2	1	3	+	WE	Alive, NED, 6.6
2	52 F A	P L 3.3	4	Nerve symptoms; atopic dermatitis; pleomorphic adenoma 8 years previous	+	4	2b	4	+	RE	Dead, disseminated disease (lung, brain), 4.2
3	60 F A	P L 3.0	3	Ruptured cyst; Warthin tumor 16 years previous	+	2	2b	4	+	RE, Rads, Chemo	Alive, NED, 9.4
4	46 M A	S R 5.8	18	Hypertension	+	3	0	3	+	RE, Rads, Chemo	Alive, NED, 8.0
5	56 F B	P R 2.1	3	Facial weakness	+	2	0	2	−	RE, Rads	Alive, NED, 1.0
6	50 M B	P L 3.2	60		−	2	0	2	−	WE, Rads	Alive, NED, 0.3
7	50 F W	P L 1.5	12	Dermatomyositis	+	1	0	1	+	WE, Rads	Alive, NED, 1.6
8	53 F W	P L 1.6	11		+	1	0	1	+	RE	Dead, NED, 6.1
9	60 F W	P L 1.1	12	Facial weakness; fell with facial injury	−	1	2b	4	−	WE, Rads	Alive, NED, 2.0
10	77 F W	S L 3.0	36	Skin basal cell carcinomas; pleomorphic adenoma 5 years previous; history of lung and colon carcinomas	+	2	1	3	−	WE	Dead, NED, 4.4
11	42 M W	P L 0.7	1	Childhood leukemia at age 8 treated by radiation and chemotherapy	−	1	0	1	−	WE, Rads	Alive, NED, 6.0
12	54 M W	P R 3.0	2		+	2	0	2	−	RE	Alive, NED, 4.0
13	54 M W	P R 4.5	3		+	3	3b	4	+	RE, Rads	Alive, NED, 0.6
14	59 M W	P R 4.2	7		+	4	3b	4	+	RE, Rads, chemo	Alive, disseminated disease (bone), 1.9
15	71 M W	P L 2.5	3		+	2	2b	4	−	RE, Rads	Alive, NED, 0.8
16	85 M W	P L 4.0	8	Rheumatoid arthritis	+	3	1	3	−	RE	Alive, NED, 10.2

Patients ordered by race, sex and then age. pT, primary tumor category; pN, regional lymph node category; AJCC8, American Joint Committee on Cancer staging manual 8th edition

LESA lymphoepithelial sialadenitis, EBER Epstein-Barr virus encoding region, F female, M male, A Asian, B black, W white, S submandibular, P parotid, R right, L left, WE wide excision, RE radical excision, Rads radiotherapy, chemo chemotherapy, NED no evidence of disease